Cetuximab funded for some bowel cancer patients from 1 November 2024
October 10, 2024
GCF is delighted to see today’s announcement that Erbitux Cetuximab (Erbitux) will be funded for a group of bowel cancer patients.From November 1st, this targeted treatment will be available for patients with metastatic colorectal cancer on the left side of the colon, with...
The Gut Cancer Foundation (GCF) has today provided feedback to Pharmac as part of their consultation process for funding the liver cancer treatment, lenvatinib (Lenvima). Lenvatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an ...
Access to Keytruda Widened from 1 October 2024.
September 10, 2024
The Gut Cancer Foundation is heartened to receive news of widened access of pembrolizumab (Keytruda) for microsatellite instability high or deficient mismatch repair (MSI-H/dMMR) colorectal cancer (CRC) patients. Pharmac has listened to clinici...
GCF Provides Feedback for the Consultation on Pharmac Proposal to Widen Access to Pembrolizumab for Colorectal Cancer.
August 15, 2024
Earlier this month, Pharmac called for feeback on their proposal to widen access to Pembrolizumab to treat microsatellite instability-high or deficient mismatch repair (MSI-H/dMMR) colorectal cancer.We and the community we represent welcome the proposal. For a patient g...
Update on Medicine Funding for Liver Cancer
August 15, 2024
The Gut Cancer Foundation has today written to Pharmac in response to news released on Friday August 9th that they have issued a Future Procurement Opportunity (FPO) for the cancer treatment bevacizumab.Aotearoa/New Zealand remains an outlier with no funded systemic options ...
Gut Cancer Foundation Welcomes News of Funded Immunotherapy for Colorectal Cancer Patients
July 5, 2024
The Gut Cancer Foundation is delighted by Pharmac’s announcement today that they are proposing to fund Pembrolizumab (Keytruda) for patients with microsatellite instability-high or deficient mismatch repair (MSI-H/dMMR) colorect...
New Treatments Funded for Gut Cancer Patients
June 25, 2024
Yesterday's announcement of $604 million investment over four years to fund up to 26 cancer treatments is fantastic news for New Zealanders living with cancer. We are very pleased to see that the announcement includes the fulfilment of a promise to fund 2 new cancer drugs fo...
Open Letter to Prime Minister Chistopher Luxon, Minister of Finance Nicola Willis, and the Associate Minister of Health (Pharmac) David SeymourDear Prime Minister Christopher Luxon, Minister of Finance Nicola Willis, and Associate Minister of Health (Pharmac) David Seymour.&...
Cancer Patients Missing Out
May 30, 2024
The Gut Cancer Foundation is deeply disappointed in the failure of this government to stick to National’s pre-election pledges to provide funding for new cancer treatments.Whilst we welcome the announcement of funding for Pharmac, this only funds existing treatments, not t...
Cancer Research Month
May 14, 2024
Research is a vital part of cancer care and is how we improve outcomes for the future. Clinical trials are how we put research into practice. They take studies from the bench to the bedside, advancing discoveries made in laboratories into treatments aiming to extend life, im...
Loading...
TAGS
Pancreatic Cancerclinical trialPanCan GalaPancreasresearchShine A LightauctionBig Purple Dinnerbowel cancercancer drugsCancer preventionCDH1Gastric Cancergut microbiomeHereditary Diffuse Gastric CancermedicinesmicrobiomePancare FoundationPancreatic Cancer Awareness MonthPatient Supportpharmacstomach cancerstomach cancer awarenessstomach cancer awareness weektreatment access
Loading...